BACE1 plays a critical role in the pathophysiology of Alzheimer’s disease, and its rates of activity and concentrations have been found to be elevated in body fluids (such as plasma and CSF) and in the brains of Alzheimer’s disease patients [85,86,87]. This evidence concerns the gene BACE1 and early-onset autosomal dominant Alzheimer disease.